Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hao Liu
Observed names:
H. Liu,
Liu, H.
Institution:
Tianjin Medical University Cancer Institute and Hospital
Observed institutions:
Henan University of Science and Technology,
Tianjin Medical University Cancer Institute and Hospital,
Tongde Hospital of Zhejiang Province,
Shanxi Provincial Cancer Hospital,
Tianjin Medical University
ORCID:
0000-0002-6040-4651
Observed ORCID:
0000-0002-6040-4651
OpenAlex ID:
A5069469522
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review
2024
·
Jingwen Kuang
, Hao Liu
, et al.
·
Medical Oncology
·
5
PDF
123P Goserelin 10.8 mg and 3.6 mg depots in breast cancer (BC): A large real-world noninferiority study
2024
·
Y. Wang
, X. Wang
, et al.
·
ESMO Open
·
3
PDF
122eP Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through mTOR-S6K/4EBP1-mediated upregulation of Wip1
2026
·
N. Wang
, B. Wang
, et al.
·
ESMO Open
Ubiquitin-Specific Peptidase 9X Inhibition for Antitumor Immunity Via Programmed Death Ligand 1 Ubiquitination and T-Cell Activation
2025
·
Wei Chen
, Tao Ma
, et al.
·
Research Square
PDF
A randomized, double-blind comparison of tenofovir alafenamide versus tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine for initial HIV-1 treatment: Week 96 results
2016
·
Clumeck, N.
, Wohl, D.
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Show more works
View as search
Works count:
5
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type